Second Sight Medical Products, Inc. (EYES) News

Second Sight Medical Products, Inc. (EYES): $2.22

0.20 (+9.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter EYES News Items

EYES News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest EYES News From Around the Web

Below are the latest news stories about Second Sight Medical Products Inc that investors may wish to consider to help them evaluate EYES as an investment opportunity.

EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.

EYES stock is up 15% today on news that Second Sight Medical is making a strategic acquisition.

Joel Baglole on InvestorPlace | February 8, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning!

William White on InvestorPlace | February 8, 2022

Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical

Second Sight Medical Products Inc (NASDAQ: EYES) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction. Second Sight Medical develops implantable visual prosthetics. Under the agreement, Nano Precision Medical will merge with a wholly-owned subsidiary of Second Sight. The surviving company Nano Precision Medical will be owned by Second Sight. The newly-formed merged company will focus on developing innovative implants for chronic diseases. The combined company will b

Yahoo | February 8, 2022

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

LOS ANGELES & EMERYVILLE, Calif., February 07, 2022--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight") and Nano Precision Medical, Inc. ("NPM"), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and dev

Yahoo | February 7, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, trader!

William White on InvestorPlace | November 17, 2021

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

LOS ANGELES, August 11, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announces that the Company received a grant supplement from the National Institutes of Health (NIH) to fund a qualitative study to gather critical insights into how profoundly blind people weigh the risks and benefits of visual neuroprostheses

Yahoo | August 11, 2021

Second Sight Medical Products Announces Closing of Public Offering

LOS ANGELES, June 25, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the closing of its previously announced underwritten public offering of 11,500,000 shares of its common stock at a public offering price of $5.00 per share, which includes 1,500,000 shares sold upon full exercise of the underwrit

Yahoo | June 25, 2021

Second Sight Medical Products Announces Pricing of Public Offering

LOS ANGELES, June 23, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the pricing of its underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $50,000,000, before deducting underwriting discounts, commissions and o

Yahoo | June 23, 2021

Second Sight Medical Products Announces Proposed Public Offering of Common Stock

LOS ANGELES, Jun 22, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company") a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. The offering is subject to market conditions and there can be no assur

Yahoo | June 22, 2021

Is Second Sight Medical Products Inc (EYES) A Good Stock To Buy?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 866 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of March 31st, 2020. […]

Yahoo | June 14, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4708 seconds.